RxSight, Inc. 8-K

What Happened
RxSight, Inc. (RXST) filed an 8‑K on December 23, 2025 reporting a planned leadership transition for its Chief Financial Officer. The company and CFO Shelley Thunen entered into a transition agreement and release of claims and also signed a consulting agreement under which Ms. Thunen will provide certain transition services effective as of her employment separation date.

Key Details

• Company: RxSight, Inc. (RXST); Filing: Form 8‑K dated December 23, 2025.
• Officer: Shelley Thunen — identified as the Company’s Chief Financial Officer and principal financial and accounting officer.
• Agreements: Transition Agreement (including a release of claims) and a Consulting Agreement to provide transition services.
• Disclosure: The leadership transition was reported under Regulation FD; the filing states this disclosure is not “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly stated.

Why It Matters
Executive transitions at the CFO level can affect investor perceptions of financial leadership and continuity. The filing confirms an orderly transition with consulting support from the outgoing CFO but does not disclose the separation date, financial terms, or a named successor — key items investors may watch for in subsequent filings or company communications.